Cargando…
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
BACKGROUND: Breast cancer is a leading cause of morbidity and mortality worldwide. Although mammography screening is available, there is an ongoing interest in improved early detection and prognosis. Herein, we have analysed a combination of serological biomarkers in a case–control cohort of sera ta...
Autores principales: | Kazarian, Anna, Blyuss, Oleg, Metodieva, Gergana, Gentry-Maharaj, Aleksandra, Ryan, Andy, Kiseleva, Elena M, Prytomanova, Olga M, Jacobs, Ian J, Widschwendter, Martin, Menon, Usha, Timms, John F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318971/ https://www.ncbi.nlm.nih.gov/pubmed/28081538 http://dx.doi.org/10.1038/bjc.2016.433 |
Ejemplares similares
-
Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015) -
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017) -
Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset
por: Blyuss, Oleg, et al.
Publicado: (2015) -
Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
por: Pedersen, J W, et al.
Publicado: (2013) -
Improved early detection of ovarian cancer using longitudinal multimarker models
por: Whitwell, Harry J., et al.
Publicado: (2020)